Podcast appearances and mentions of dana farber brigham

CANCER. It's a scary word. And when it comes to skin cancer, the fear is no different. May is Skin Cancer Awareness Month and this time is dedicated to educating people about skin cancers of all kinds. Did you know that globally, between 2 and 3 million cases of non-melanoma skin cancers are diagnosed each year? That's a staggering number, and it means that the chances of being diagnosed with skin cancer are higher than you might think. Be sure to listen to this week's podcast episode featuring Dr. Emily Ruiz, where we talk about non-melanoma skin cancers, tips for preventing skin cancer, and available treatment options. Key Takeaways: - Skin cancer is the most common type of cancer in the world, with basal cell carcinoma and squamous cell carcinoma being the most prevalent forms. - Sun protection is crucial in preventing skin cancer, including wearing protective clothing, using sunscreen, and avoiding midday sun exposure. - The Skin Cancer Champions online community provides support and resources for patients with skin cancer, including information on treatment options and connecting with others. - Other prevention methods include taking nicotinamide supplements and using chemo creams to remove damaged skin. - Early detection and treatment of skin cancer is important for better outcomes, and regular check-ups with a dermatologist are recommended for high-risk individuals. In This Episode: (6:50) Understanding the Different Types of Skin Cancer (9:50) How Do You Get Skin Cancer (11:48) Prevention Methods for Skin Cancer (20:00) Skin Cancer Champions ( 25:22) Nicotinamide   (30:30) Tips for People who have been Diagnosed with Skin Cancer Get Dr. Mina's free PDF on How to create Healthy Skin Habits here. Download the free eBook 'Skincare Myths Busted' here. Emily Ruiz, MD, MPH, is an Associate Physician at the Mohs and Dermatologic Surgery Center at Dana-Farber/Brigham and Women's Cancer Center, an Associate Professor in Dermatology at Harvard Medical School, Director of the High-Risk Skin Cancer Clinic at Dana Farber/Brigham and Women's Hospital, and Program Director of the Micrographic Surgery and Dermatologic Oncology Fellowship. Dr. Ruiz received her undergraduate degree from Duke University, medical degree from New York University School of Medicine, and Master of Public Health Degree from Harvard School of Public Health. She completed an internship in internal medicine at New York University School of Medicine, dermatology residency at Albert Einstein College of Medicine, and fellowship in Micrographic Surgery and Dermatologic Oncology at Brigham and Women's Hospital. Skin Cancer Champions is an online forum for those diagnosed with non-melanoma skin cancers. It's a place where you can find accurate information, connect with others who are on a similar journey, and feel supported every step of the way.  Follow Dr. Mina here:-  https://instagram.com/drminaskin https://www.facebook.com/drminaskin https://www.youtube.com/@drminaskin For more great skin care tips, subscribe to The Skin Real Podcast or visit www.theskinreal.com Baucom & Mina Derm Surgery, LLC Email - scheduling@atlantadermsurgery.com  Contact - (404) 844-0496 Instagram - https://www.instagram.com/baucomminamd/ Thanks for listening! The content of this podcast is for entertainment, educational, and informational purposes and does not constitute formal medical advice.

Dr Akila Viswanathan and Dr Tracy Balboni from Harvard Medical School and Dana-Farber/Brigham and Women's Cancer Center discuss the latest developments in palliative care for Seminars in Radiation Oncology.

Today's podcast episode is part of the “Voices” series and is brought to you by the Diversity, Equity & Inclusion Committee. Dr. Quoc-Dien Trinh, associate professor of surgery at Harvard Medical School; chief of urology at Brigham and Women's Faulkner Hospital and co-director of the prostate cancer program at the Dana-Farber/Brigham and Women's Cancer Center, sits down with his mentee, Jameshisa Alexander, first year medical student at the Morehouse School of Medicine, to discuss the inaugural FUTURE in Urology Program held in conjunction with AUA's Annual Meeting in April 2023.

Chris Devin was diagnosed with multiple myeloma at the age of 45 during the heart of the Covid-19 pandemic. Chris immediately underwent five straight days on intensive radiation that stopped his excruciating headaches and readied him for a clinical trial at Dana-Farber/ Brigham.  Devin and his wife Erica have been transparent with their kids about their father's situation.  See omnystudio.com/listener for privacy information.

Today on After the Crisis, nutrition and fitness expert Stacy Kennedy reveals the three obstacles every person must overcome in order to maintain a healthy lifestyle. Listen in as Victoria and Stacy discuss weighing the cost of healthy food vs. fast food, how regular activity supports weight management, and why sleep is critical to gut health. Stacy is a board-certified specialist in oncology nutrition and an integrative nutritionist for Reboot with Joe. Stacy is featured in the award-winning documentary films, Fat, Sick & Nearly Dead and Fat, Sick & Nearly Dead 2, is a senior clinical nutritionist at the Dana-Farber/Brigham & Women’s Cancer Center Hospital, and is an adjunct professor in wellness and health coaching at William James College. Stacy holds a BS degree in dietetics from Indiana University and a master’s in public health from the University of North Carolina at Chapel Hill. You can connect with Betty in the following way: Instagram: @StacyKennedyRD Learn more about Upshoot: https://www.myupshoot.life/victoriaenglishmartin/products Learn more about Fat, Sick, and Nearly Dead:  Fat, Sick and Nearly Dead - Wikipedia If you have experienced a crisis and are looking for a place to share your story and gain support, join the After the Crisis with Victoria community here. You can also subscribe to the podcast for future episodes.

What is the number one cause of pancreatic cancer? What are the early warning signs of this disease? And how are researchers making progress in the treatment of pancreatic cancer overall? In this episode of Cancer Mythbusters from Dana-Farber Cancer Institute, we talk about some of the most common questions and myths about pancreatic cancer with Brian Wolpin, director of the Gastrointestinal Cancer Center at Dana-Farber/Brigham and Women's Cancer Center.

Episode 10 features ACMS member Emily Ruiz, MD, MPH, Director of High Risk-Skin Cancer Clinic, Dana-Farber/Brigham and Women's Cancer Center, Assistant Professor at Harvard Medical School. Dr. Ruiz discusses her article, Performance of the American Joint Committee on Cancer Staging Manual, 8th Edition vs the Brigham and Women's Hospital Tumor Classification System for Cutaneous Squamous Cell Carcinoma, published in the JAMA Dermatology in July of 2019.

As of 2019, colorectal cancer is the third most common cancer diagnosed in men and women in the United States — but survival after diagnosis has been gradually increasing in the past decade due to advances in treatment. However, since 1994, cases of young-onset colorectal cancer have increased by 51 percent, according to the National Cancer Institute. In March 2019, Dana-Farber/Brigham and Women's Cancer Center announced the launch of the Young-Onset Colorectal Cancer Center, which focuses exclusively on the care of colorectal cancer patients under age 50, in an effort to address the alarming increase in rates among young adults. In this episode of Cancer Mythbusters, we interview Dr. Jeffrey Meyerhardt, clinical director of the Gastrointestinal Cancer Center at Dana-Farber. He answers common questions about treatment and research, family history, and ways you can reduce your risk, whether you’re a young adult or older.

Welcome to Prostate Cancer & You, a series of podcasts sponsored by the Massachusetts Prostate Cancer Coalition. Today’s podcast features an interview with Quoc-Dien Trinh, MD, assistant professor of surgery at Harvard Medical School  and co-director of the Dana-Farber/Brigham and Women’s Prostate Cancer Center.  On this podcast he discusses the gap in prostate cancer survival of African American men compared to Caucasian men. His data shows that the biological differences in tumor aggressiveness among African American men may have been exaggerated, and the gap in survival is more likely to be the result of racial inequity and lack of access to quality care. At the May 10 Prostate Cancer Symposium his session is “Racial Variations in Prostate Cancer Care: Differences or disparities.” Go here for more information and to register.

What should we eat, and what shouldn’t we eat? What keeps cancer patients healthy, and what can help fend off cancer in the first place? These are big questions, and it can be hard to tell the difference between a nutritional myth and a nutritional fact. “Superfood,” a relatively new term, refers to foods that have certain supposed very good health benefits. In this episode, Stacy Kennedy, MPH, RD, a senior clinical nutritionist in Nutrition Services at Dana-Farber/Brigham and Women’s Cancer Center, helps us uncover what the real deal is with these foods — and whether they can help cancer patients.

Episode #11: Watch & Wait Protocol by Dana-Farber/Brigham and Women's Cancer Center

This episode features discussion on Heated Intraperitoneal Chemotherapy (HIPEC) treatment. The experts joining the podcast to discuss this type of care are Dr. Nelya Melnitchouk and Dr. Tom Abrams from the GI team at the Dana Farber/Brigham and Women's Cancer Center in Boston. HIPEC differs from other treatments because of the specific and targeted delivery method. The chemo does not circulate through the entire body during HIPEC. It only is directed at the cancerous cells in the abdomen area.

Dr. Jeffrey Meyerhardt is the Clinical Director of the Gastrointestinal Cancer Center and Senior Physician at Dana-Farber Cancer Institute. In his research, Dr. Meyerhardt, who also is an Associate Professor of Medicine at Harvard Medical School and co-leader of the Center for Colon and Rectal Cancer at Dana-Farber/Brigham and Women’s Cancer Center, focuses primarily on […] The post Advances in Personalized and Precision Medicine, with Dr. Jeffrey Meyerhardt, M.D., MPH appeared first on The Colon Cancer Podcast.

Although they were both diagnosed with early stage breast cancer, Amanda and Judy elected two very different surgical treatments. They discuss their surgery options and decisions along with Dr. Tari King, chief of breast surgery at the Susan F. Smith Center for Women’s Cancers at Dana-Farber/Brigham and Women’s Cancer Center.